When we wondered if the expression of CD44v6 and CD114 genes can be associated with stage 4 NB patients’ outcome, consulting public data-sets from the R2 Genomics Analysis and Visualization Platform we found that CD114 gene resulted not sufficiently significant, while CD44v6 gene does not exist in none database. This evidence concerns the gene CSF3R and neuroblastoma.